We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 11-20 of 877

Six tips for demonstratives in PTAB hearings
  • Foley & Lardner LLP
  • USA
  • July 7 2015

Oral hearings before the PTAB are the time to shine, to convince the judges why your position is right, why your opponent's position is wrong, and to


Examination delay earns Patent Term Adjustment only in one application
  • Foley & Lardner LLP
  • USA
  • June 30 2015

In Mohsenzadeh v. Lee, the Federal Circuit affirmed the district court's decision that the USPTO's delay in issuing a Restriction Requirement in a


Federal Circuit invalidates another diagnostic patent
  • Foley & Lardner LLP
  • USA
  • June 30 2015

In Ariosa Diagnostics, Inc. v. Sequenom, Inc., Slip Op. 2014-1139, 2014-114 (Fed. Cir. June 12, 2015), the U.S. Court of Appeals for the Federal


Federal Circuit strikes final blow to Celebrex patent
  • Foley & Lardner LLP
  • USA
  • June 25 2015

In 2008, the Federal Circuit determined that claims 1-4 and 11-17 of U.S. Patent No. 5,760,068 were invalid for obviousness-type double patenting


Federal Circuit reverses unreasonable PTAB claim construction, upholds idle free standard for motions to amend
  • Foley & Lardner LLP
  • USA
  • June 23 2015

The Federal Circuit decision in Microsoft Corp. v. Proxyconn, Inc., addressed several important issues relating to post-grant patent trials conducted


USPTO pilots expedited patent appeal program but at what price?
  • Foley & Lardner LLP
  • USA
  • June 18 2015

In a June 15, 2015 Federal Register Notice, the USPTO announced the Expedited Patent Appeal Pilot program, which will run until 2,000 ex parte patent


Federal Circuit hold Sequenom diagnostic method patent invalid under 101
  • Foley & Lardner LLP
  • USA
  • June 15 2015

The Federal Circuit has issued its decision in Ariosa Diagnostic, Inc. v. Sequenomn, Inc., affirming the district court's finding that


Federal Circuit finds nunc pro tunc agreement does not confer standing
  • Foley & Lardner LLP
  • USA
  • June 9 2015

The tenuous nature of an exclusive licensee's standing to enforce a patent was something I learned early in my legal career, when I was a judicial


Federal Circuit hears oral arguments in Neupogen Biosimilar Case
  • Foley & Lardner LLP
  • USA
  • June 3 2015

On June 3, 2015, the Federal Circuit heard oral arguments in Amgen v. Sandoz regarding the patent dispute resolution provisions of the Biologics


Supreme Court on induced infringement: good-faith belief of invalidity not a defense and knowledge of infringement required
  • Foley & Lardner LLP
  • USA
  • June 2 2015

In a 6-2 decision this week, the United States Supreme Court in Commil USA, LLC v. Cisco Systems, Inc., 575 U.S. ____ (2015) held that an accused